Li Z, Jiang J, Cai K, Qiao Y, Zhang X, Wang L
Bone Res. 2025; 13(1):26.
PMID: 39994205
PMC: 11850813.
DOI: 10.1038/s41413-025-00400-9.
Nelson V, Eadie A, Perez L, Madhu M, Platt M, Mercer A
Biomolecules. 2024; 14(10).
PMID: 39456232
PMC: 11506509.
DOI: 10.3390/biom14101299.
Libra A, Sciacca E, Muscato G, Sambataro G, Spicuzza L, Vancheri C
Int J Mol Sci. 2024; 25(15).
PMID: 39125962
PMC: 11313529.
DOI: 10.3390/ijms25158392.
Zheng Z, Peng F, Zhou Y
Chin Med J Pulm Crit Care Med. 2024; 2(2):72-79.
PMID: 38962100
PMC: 11221783.
DOI: 10.1016/j.pccm.2024.04.003.
Humeres C, Shinde A, Tuleta I, Hernandez S, Hanna A, Huang S
Circ Res. 2024; 135(3):453-469.
PMID: 38899461
PMC: 11257802.
DOI: 10.1161/CIRCRESAHA.123.323360.
Circular RNAs and their roles in idiopathic pulmonary fibrosis.
Surendran A, Huang C, Liu L
Respir Res. 2024; 25(1):77.
PMID: 38321530
PMC: 10848557.
DOI: 10.1186/s12931-024-02716-2.
Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease.
Kogiso T, Takayanagi K, Ishizuka T, Otsuka M, Inai K, Ogasawara Y
PLoS One. 2024; 19(1):e0296375.
PMID: 38166061
PMC: 10760884.
DOI: 10.1371/journal.pone.0296375.
The Regulation of Fatty Acid Synthase by Exosomal miR-143-5p and miR-342-5p in Idiopathic Pulmonary Fibrosis.
Hayek H, Rehbini O, Kosmider B, Brandt T, Chatila W, Marchetti N
Am J Respir Cell Mol Biol. 2023; 70(4):259-282.
PMID: 38117249
PMC: 11478129.
DOI: 10.1165/rcmb.2023-0232OC.
Imperatorin ameliorates pulmonary fibrosis via GDF15 expression.
Tsai C, Chen Y, Li Y, Wu C, Chang P, Yeh W
Front Pharmacol. 2023; 14:1292137.
PMID: 38111379
PMC: 10725920.
DOI: 10.3389/fphar.2023.1292137.
ZLN005 improves the protective effect of mitochondrial function on alveolar epithelial cell aging by upregulating PGC-1α.
Ma M, Gao Y, Qiu X, Gui X, Tian Y, Tian M
J Thorac Dis. 2023; 15(11):6160-6177.
PMID: 38090292
PMC: 10713321.
DOI: 10.21037/jtd-23-815.
Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.
Bonella F, Spagnolo P, Ryerson C
Drugs. 2023; 83(17):1581-1593.
PMID: 37882943
PMC: 10693523.
DOI: 10.1007/s40265-023-01950-0.
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
Park S, Mai M, Ploszaj M, Cai H, McGarvey L, Mueller C
PLoS One. 2023; 18(10):e0291948.
PMID: 37819895
PMC: 10566687.
DOI: 10.1371/journal.pone.0291948.
A first-in-human phase I study of SHR-1906, a humanized monoclonal antibody against connective tissue growth factor, in healthy participants.
Song L, Zhou H, Ye P, Li Q, Chen K, Zhang Y
Clin Transl Sci. 2023; 16(12):2604-2613.
PMID: 37766387
PMC: 10719490.
DOI: 10.1111/cts.13654.
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies.
Guo H, Sun J, Zhang S, Nie Y, Zhou S, Zeng Y
Front Pharmacol. 2023; 14:1205948.
PMID: 37608885
PMC: 10440605.
DOI: 10.3389/fphar.2023.1205948.
Towards a Unified Approach in Autoimmune Fibrotic Signalling Pathways.
Sisto M, Lisi S
Int J Mol Sci. 2023; 24(10).
PMID: 37240405
PMC: 10219329.
DOI: 10.3390/ijms24109060.
Extracellular Targets to Reduce Excessive Scarring in Response to Tissue Injury.
Fertala J, Wang M, Rivlin M, Beredjiklian P, Abboud J, Arnold W
Biomolecules. 2023; 13(5).
PMID: 37238628
PMC: 10216402.
DOI: 10.3390/biom13050758.
Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis.
Thong L, McElduff E, Henry M
Life (Basel). 2023; 13(2).
PMID: 36836843
PMC: 9963632.
DOI: 10.3390/life13020486.
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis.
Kadefors M, Berlin F, Wildt M, Dellgren G, Rolandsson Enes S, Aspberg A
Front Pharmacol. 2022; 13:953771.
PMID: 36120350
PMC: 9473336.
DOI: 10.3389/fphar.2022.953771.